✦ LIBER ✦

Development of meningeal leukemia (L1210) during treatment of subcutaneously inoculated mice with methotrexate

✍ Scribed by Louis B. Thomas; Michael A. Chirigos; Stewart R. Humphreys; Abraham Goldin

Publisher: John Wiley and Sons
Year: 1964
Tongue: English
Weight: 910 KB
Volume: 17
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196403)17:3<352::aid-cncr2820170311>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superiority of conventional intrathecal

Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia

✍ Margaret P. Sullivan; G. B. Humphrey; Teresa J. Vietti; Mary Ellen Haggard; Elis 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

In the treatment of patients with meningeal leukemia, conventional intrathecal methotrexate therapy followed by maintenance intrathecal methotrexate at intervals of 8 weeks has been shown superior to an intensive, unmaintained intrathecal methotrexate induction regimen, and to neuroaxis radiotherapy

Nuclear magnetic resonance abnormalities

Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate

✍ Reinin Asato; Yuichi Akiyama; Masatoshi Ito; Masaru Kubota; Ryousuke Okumura; Yu 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 847 KB